Diabetes, Vol 46, Issue 9 1459-1467, Copyright © 1997 by American Diabetes Association

ARTICLES

Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study

M Fuchtenbusch, K Ferber, E Standl and AG Ziegler
Diabetes Research Institute and Academic Hospital Munchen-Schwabing, Munich, Germany.

Women with gestational diabetes mellitus (GDM) have a considerable risk of developing diabetes later in life. To determine the predictive value of autoantibody markers in gestational diabetic pregnancy for the development of type 1 diabetes postpartum, we tested 437 patients with GDM (289 women treated with diet only [GDM-A] and 148 requiring insulin treatment during pregnancy [GDM-B]) for antibodies to islet cells (ICAs), GAD (GADAs), and tyrosine phosphatase ICA512/IA-2 (IA2As). We prospectively followed them with repeated oral glucose tolerance tests and antibody determinations for up to 7 years postpartum (mean, 1.6 years; range, 0-7.2 years). The cumulative risk of diabetes up to 5 years postpartum was 17% (95% CI 12-22%). The risk of type 1 diabetes was 3% (2-5%) by 9 months and 7% (4-9%) 2 years after delivery. At delivery, 8.5% of all patients were ICA+, 9.5% were GADA+, 6.2% were IA2A+, and 18.1% were positive for at least one antibody (12.6% for GDM-A vs. 30.4% for GDM-B, P < 0.0001). During follow-up, GADAs persisted in 75%, ICAs in 35%, and IA2As in 30% of the subjects positive for the respective marker at delivery. By 2 years postpartum, 29% (19-39%) of patients positive for at least one antibody developed type 1 diabetes, compared with 2% (1-4%) of antibody-negative patients (P < 0.0001). Thereby, the risk for type 1 diabetes 2 years postpartum increased with the number of antibodies present at delivery from 17% (6-28%) for one antibody, to 61% (30-91%) for two antibodies, and to 84% (55-100%) for 3 antibodies. Risk of progression to type 1 diabetes postpartum was also associated with the status of parity. Women with one or more pregnancies before the index pregnancy had a higher risk for type 1 diabetes 2 years after delivery (14.7% [4.9.-24.5%]) than women having their first (i.e., index) pregnancy (5% [2.9-7.1%]) (P < 0.006). A comparison of different prediction strategies showed that single antibody screening with GADA yielded the highest sensitivity of 63% (45-75%), compared with ICA (48% [31-65%]) and IA2A (34% [13-47%]). Combined screening with two autoantibodies increased sensitivity to 74% (58-90%) and 75% (60-92%) when using GADA plus ICA or GADA plus IA2A, respectively. Screening with all three markers improved sensitivity further to 82% (67-100%). Beta-cell autoantibodies determined at delivery in women with GDM are highly predictive for the development of type 1 diabetes postpartum. Autoantibody screening in pregnant women with GDM from populations at high risk for type 1 diabetes should therefore be considered to allow early diagnosis and appropriate therapy.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				C. Nilsson, D. Ursing, C. Torn, A. Aberg, and M. Landin-Olsson Presence of GAD Antibodies During Gestational Diabetes Mellitus Predicts Type 1 Diabetes Diabetes Care, August 1, 2007; 30(8): 1968 - 1971. [Abstract] [Full Text] [PDF]

				A. de Leiva, D. Mauricio, and R. Corcoy Diabetes-Related Autoantibodies and Gestational Diabetes Diabetes Care, July 1, 2007; 30(Supplement_2): S127 - S133. [Full Text] [PDF]

				J. L. Kitzmiller, L. Dang-Kilduff, and M. M. Taslimi Gestational Diabetes After Delivery: Short-term management and long-term risks Diabetes Care, July 1, 2007; 30(Supplement_2): S225 - S235. [Full Text] [PDF]

				I. Y. Jarvela, J. Juutinen, P. Koskela, A.-L. Hartikainen, P. Kulmala, M. Knip, and J. S. Tapanainen Gestational Diabetes Identifies Women at Risk for Permanent Type 1 and Type 2 Diabetes in Fertile Age: Predictive role of autoantibodies. Diabetes Care, March 1, 2006; 29(3): 607 - 612. [Abstract] [Full Text] [PDF]

				K. Lobner, A. Knopff, A. Baumgarten, U. Mollenhauer, S. Marienfeld, M. Garrido-Franco, E. Bonifacio, and A.-G. Ziegler Predictors of Postpartum Diabetes in Women With Gestational Diabetes Mellitus Diabetes, March 1, 2006; 55(3): 792 - 797. [Abstract] [Full Text] [PDF]

				N. H. Cho, S. Lim, H. C. Jang, H. K. Park, and B. E. Metzger Elevated Homocysteine as a Risk Factor for the Development of Diabetes in Women With a Previous History of Gestational Diabetes Mellitus: A 4-year prospective study Diabetes Care, November 1, 2005; 28(11): 2750 - 2755. [Abstract] [Full Text] [PDF]

				M. Albareda, A. Caballero, G. Badell, S. Piquer, A. Ortiz, A. de Leiva, and R. Corcoy Diabetes and Abnormal Glucose Tolerance in Women With Previous Gestational Diabetes Diabetes Care, April 1, 2003; 26(4): 1199 - 1205. [Abstract] [Full Text] [PDF]

				L. L. Moore, M. L. Bradlee, M. R. Singer, K. J. Rothman, and A. Milunsky Chromosomal Anomalies among the Offspring of Women with Gestational Diabetes Am. J. Epidemiol., April 15, 2002; 155(8): 719 - 724. [Abstract] [Full Text] [PDF]

				D. B. Sacks, D. E. Bruns, D. E. Goldstein, N. K. Maclaren, J. M. McDonald, and M. Parrott Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus Clin. Chem., March 1, 2002; 48(3): 436 - 472. [Abstract] [Full Text] [PDF]

				T. STALLMACH, G. HEBISCH, K. MEIER, J. W. DUDENHAUSEN, and M. VOGEL Rescue by Birth: Defective Placental Maturation and Late Fetal Mortality Obstet. Gynecol., April 1, 2001; 97(4): 505 - 509. [Abstract] [Full Text] [PDF]

				S Virjee, S Robinson, and D G Johnston Screening for diabetes in pregnancy J R Soc Med, January 10, 2001; 94(10): 502 - 509. [Full Text] [PDF]

				K. M. Ferber, E. Keller, E. D. Albert, and A.-G. Ziegler Predictive Value of Human Leukocyte Antigen Class II Typing for the Development of Islet Autoantibodies and Insulin-Dependent Diabetes Postpartum in Women with Gestational Diabetes J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2342 - 2348. [Abstract] [Full Text]